Literature DB >> 32963280

Cross-sectional study of Staphyloccus lugdunensis prevalence in cats.

Karolina Bierowiec1.   

Abstract

Staphylococcus lugdunensis is a commensal bacterium in humans and other animals that can cause serious infections. The aim of this research was to estimate the frequency of S. lugdunensis in pet cats and to characterize the S. lugdunensis isolates obtained. The prevalence of S. lugdunensis was 0.77% (4/523) in healthy cats and 1.23% (1/81) in sick cats. The isolates (N = 5), which colonized conjunctival sacs, nares, and the anus, were almost fully phenotypically sensitive to antibiotics, but harbored resistance genes to four chemotherapeutic groups. Their sequence types (STs) included ST2, ST3, ST9, and ST15. There was detected a far lower prevalence of S. lugdunensis in pet cats than is reported in the human population. Nevertheless, the phenotypic and genotypic properties of S. lugdunensis isolates found in the current study were very similar to those described previously in isolates of human origin.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32963280      PMCID: PMC7508828          DOI: 10.1038/s41598-020-72395-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Coagulase-negative staphylococci (CoNS) are common commensal bacteria of the skin and mucosal membranes of mammals[1,2]. The importance of CoNS as pathogens that cause severe hospital and community acquired infections in both human and veterinary patients has gained attention in recent years. Notably, the pathogenicity and virulence characteristics of the CoNS species Staphylococcus lugdunensis have been described as comparable to those of Staphylococcus aureus. In healthy humans, S. lugdunensis colonization of the skin (especially of the groin, toes, and axillae) has been reported to be three-fold more frequent than that of S. aureus, which colonizes mainly the nose[1]. However, clinically significant S. lugdunensis infections in humans, including infections of the skin, pelvic soft tissues, and lower extremities (including the feet) have been reported, as have cases of infective endocarditis, bone and joint infections, and septicemia due to S. lugdunensis infection[1,3-6]. Though S. lugdunensis has been isolated from healthy dogs and cats, severe S. lugdunensis infections of the urogenital tract, respiratory tract, deep tissues, and wounds have also been reported in dogs and cats[2,7]. Although S. lugdunensis is gaining attention as a cause of severe human infection, especially in cardiology and orthopedy, there is little recognition of the bacterium in veterinary medicine[4,5]. S. lugdunensis colonization of pets could potentially be dangerous for people. Therefore, the aims of the present study were to describe the prevalence of S. lugdunensis in a cat population sample, to characterize the virulence potential of S. lugdunensis isolates from cats, and to evaluate factors that may predispose cats to S. lugdunensis colonization or infection. Present work follows up from a previous study focusing on the prevalence of staphylococci in cats[8].

Materials and methods

Isolates were collected from cats that had been screened for Staphylococcus spp. colonization during the period of 2013–2019 in the Department of Epizootiology and Clinic for Birds and Exotic Animals at Wrocław University of Environmental and Life Sciences in Poland. Specimens were collected from two groups: healthy cats; and cats with symptoms of a bacterial infection of the upper respiratory tract, skin, or wound[8]. The research project was submitted to the Local Ethics Committee for Animal Experiments in Wrocław, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences. Due to the noninvasive samples collection procedure, the Ethics Committee qualified the study as research which therefore did not require any further approval from the Ethics Committee. All methods described were approved by Wroclaw University of Environmental and Life Sciences and performed in compliance with the relevant guidelines and regulations for good laboratory practice. Each cat owner has informed consented to take part in this study and filled out the proper documentation. Swabs were used to collect samples from four anatomical sites (nares, conjunctival sacs, groin, anus) in 523 healthy and 81 sick cats, and additionally from a wound, if present, on sick cats. Additionally, each cat owner filled out the questionnaire considering potential factors connected with staphylococci colonization in cats under investigation, such as animal features (age, sex, breed, medical history) and household's factors (medical occupations or previous hospitalization of household members, other animals kept in the same household and their medical history). Collected swabs were placed into 2 ml of liquid brain–heart infusion broth (BHI) (Oxoid, United Kingdom) and incubated at 37 °C for 24 h. Then the material was subcultured in Mannitol Salt Agar and blood agar plate (Oxoid, United Kingdom) and incubated for 24 h. The preliminary identification of staphylococci was according to the colony morphology, Gram staining, and detection of enzyme production (coagulase tube test; IBSS Biomed, Poland). S. lugdunensis species was identified by polymerase chain reaction (PCR) with species-specific primers performed according to previously detailed reaction conditions[9]. All the isolates of S. lugdunensis were screened for antibiotic susceptibility using both methods: phenotypic [disc diffusion and MIC (Sensititre, Staphylococcus MIC plates, Thermo Fisher Scientific, Waltham, MA, USA)] and genotypic (detections of genetic determinants of resistance). The phenotypic and genotypic antibiotic resistance of each isolate was determined as described previously[10]. S. lugdunensis was tested for slime production by the Congo red agar method, microtiter plate test, and a standard PCR technique for icaA and bap genes detection[10]. Prevalence rates of S. lugdunensis were calculated for the sick cat group and for the healthy cat group by the bootstrap method in the R Statistical Package v. 2.11.1. The statistical analysis of potential risk factors, associated with S. lugdunensis colonization in cats under investigation, was not performed due to a small number of colonized animals in both groups of cats. Staphylococcus lugdunensis allele sequence types (STs) were determined by multi-locus sequence typing (MLST) with a sequence alignment tool (MEGA X 10.1.) focusing on seven housekeeping loci described by Chassain et al.[11]. MLST was performed with sequence and profile data from Institute Pasteur https://bigsdb.pasteur.fr/staphlugdunensis/staphlugdunensis.html). I determined the ST of each S. lugdunensis isolate under investigation by using the search tool with a combination of S. lugdunensis loci in the PasteurMLST database (https://bigsdb.pasteur.fr/cgi-bin/bigsdb/bigsdb.pl?db=pubmlst_staphlugdunensis_isolates&page=profiles).

Results

In total, five distinct S. lugdunensis isolates were identified, including four from healthy cats and one from the conjunctival sack of a cat with conjunctivitis and sneezing symptoms (GenBank accession numbers of 16S RNA sequences of isolated S. lugdunensis, MT1880032–MT1880036). In most cases, S. lugdunensis was isolated alone; in the conjunctival sack of one healthy cat it was isolated with S. epidermidis. Information about the cats colonized with S. lugdunensis is summarized in Table 1.
Table 1

Characteristics of cats colonized with S. lugdunensis and isolate origin site.

Isolate IDHealth statusBreedSexAge (months)HousingOrigin site
P62HealthyRussian BlueMale8Group of catsAnus
N281HealthyCornish RexMale72Registered catteryNares
O465/2HealthyMixed-breedMale86Group of catsConjunctival sacs
P1512HealthyMixed-breedFemale24SolitaryAnus
O514SickDevon RexFemale30Registered catteryConjunctival sacs
Characteristics of cats colonized with S. lugdunensis and isolate origin site. The prevalence of S. lugdunensis in cats from Wrocław city area was 0.77% [95% confidence interval (CI) 0.02–1.51%] in healthy cats and 1.23% (95% CI 0.0–3.64%) in sick cats. The antibiotic resistance profiles and biofilm-forming properties of the investigated isolates are presented in Table 2. Although isolates exhibited robust biofilm formation on polystyrene plates, none harbored the icaA or bap gene. Four different S. lugdunensis STs were found (Table 2). The ST of S. lugdunensis isolates were deposed in the Institut Pasteur MLST database (https://bigsdb.pasteur.fr/staphlugdunensis/staphlugdunensis.html), identified as isolates 113–117.
Table 2

STs, antibiotic resistance profiles, and biofilm-forming properties of investigated S. lugdunensis isolates.

Isolate IDSTAntibiotic resistance profileBiofilm productiona
P629SMX/blaZ; tet(K), tet(M), tet(O), tet(L), ermB, ermC, vanAStrong
N2812blaZ; tet(K), tet(M), ermB, ermC, vanAStrong
O465/22SMX/blaZ; tet(K), tet(M), ermB, ermC, vanAStrong
P15123SMX/blaZ; tet(K), tet(M), ermB, ermC, vanAStrong
O51415AMP; SMX/blaZ; tet(K), tet(M), ermB, ermC, vanAStrong

SMX sulfamethoxazole, AMP ampicillin, blaZ penicillin resistance gene, tet(K)(M)(O)(L) tetracycline resistance genes, ermB/C macrolide-lincosamide-streptogramins resistance genes, vanA glycopeptide resistance gene.

aAccording to microtiter plate assay results; weak biofilm formers, 0.265 ≤ A570 < 0.422; medium-positive biofilm formers, 0.422 ≤ A570 < 0.844; strong biofilm formers, A570 ≥ 0.844.

STs, antibiotic resistance profiles, and biofilm-forming properties of investigated S. lugdunensis isolates. SMX sulfamethoxazole, AMP ampicillin, blaZ penicillin resistance gene, tet(K)(M)(O)(L) tetracycline resistance genes, ermB/C macrolide-lincosamide-streptogramins resistance genes, vanA glycopeptide resistance gene. aAccording to microtiter plate assay results; weak biofilm formers, 0.265 ≤ A570 < 0.422; medium-positive biofilm formers, 0.422 ≤ A570 < 0.844; strong biofilm formers, A570 ≥ 0.844.

Discussion

The present data indicate that S. lugdunensis is likely to be much more rare among pet cats population under investigation (~ 1%) than among humans 30–50%[12]. Notwithstanding, given the potential risk of Staphylococcus interspecies transmission, especially to human surgery patients, the prevalence of S. lungdunensis in pets should be monitored. This study provides some information about S. lugdunesnsis characteristics and carriage sites in cats, but, despite sampling a representative group of cats, the small number of isolates found limits the power of the analysis. There was observed colonization of the perineum, as has also been documented in humans[1,13]. Interestingly, two isolates were found in cats’ conjunctival sac samples. To the best of knowledge, there have been no reports of conjunctivitis or keratitis caused by S. lugdunensis in pets. However, there have been a few such cases in human patients[14,15]. Moreover, the identification of S. lugdunensis as a potential causative pathogen of cat bacterial conjunctivitis may be indicative of a wide spectrum of possible infection sites for the bacterium, which is relevant to both veterinary and human medicine. Contrary to other CoNS, S. lugdunensis remains sensitive to most antibiotics despite its pathogenicity[1,4-6,12]. Among the presently analyzed isolates, only resistances to sulfamethoxazole and ampicillin were identified. Others have identified penicillin- and erythromycin-resistant S. lugdunensis isolates, as well as S. lugdunensis isolates with susceptibility to all antibiotics tested[3,12]. Reports of S. lugdunensis isolates collected from humans harboring antibiotic resistance genes, especially genes that can confer resistance to penicillin (blaZ), macrolides (ermB/C), and tetracyclines (tetK/L/M/O)[16] indicate that S. lugdunensis has the potential to develop phenotypic resistance to antibiotic drugs. Furthermore, a report showing that bacteria exhibit lower antibiotic resistance when they are grown in plankton than when they are grown in a biofilm, indicate that standard in vitro phenotypic antibiotic resistance testing may not fully reflect the in vivo efficiency of chemoterapeutics towards S. lugdunensis[17]. The present observation of strong S. lugdunensis biofilm-forming properties is consistent with prior observations[18,19] There are currently 20 S. lugdunensis STs catalogued in the Institut Pasteur MLST database[11]. The STs identified in the current study, ST2 and ST3, are the most frequent S. lugdunensis STs found in humans, accounting for 30% of deposed isolates thus far. Further research into the occurrence of S. lugdunensis in pet animals is needed to elucidate the pathogenic potential of this ubiquitous species and its interspecies transmission risk.

Conclusion

The current study characterized the possible carriage sites for S. lugdunensis in cats in Wrocław city area, which could be used in future research design. There was detected a far lower prevalence of S. lugdunensis in pet cats than is reported in the human population. Nevertheless, the phenotypic and genotypic properties of S. lugdunensis isolates found in the current study were very similar to those described previously in isolates of human origin. Further studies are necessary, to better understand the emergence of as a veterinary and zoonotic pathogen, to evaluate the risks of interspecies transmission and potential factors connected with S. lugdunensis colonization, and to determine appropriate household infection control practices.
  17 in total

1.  Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia.

Authors:  Seong-Ho Choi; Jin-Won Chung; Eun Jung Lee; Tae Hyong Kim; Mi Suk Lee; Jae Myung Kang; Eun Hee Song; Jae-Bum Jun; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Sang-Ho Choi
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

2.  Genotypes and phenotypes of Staphylococcus lugdunensis isolates recovered from bacteremia.

Authors:  Sung-Pin Tseng; Yu-Tzu Lin; Jui-Chang Tsai; Wei-Chun Hung; Hsiao-Jan Chen; Pi-Fang Chen; Po-Ren Hsueh; Lee-Jene Teng
Journal:  J Microbiol Immunol Infect       Date:  2013-12-31       Impact factor: 4.399

Review 3.  [7 cases of Staphylococcus lugdunensis infection].

Authors:  V Sanchís-Bayarri Vaillant; R Llucian Rambla; V Sanchís-Bayarri Bernal
Journal:  An Med Interna       Date:  1999-07

4.  Carriage niches and molecular epidemiology of Staphylococcus lugdunensis and methicillin-resistant S. lugdunensis among patients undergoing long-term renal replacement therapy.

Authors:  Pak-Leung Ho; Sammy Man-Him Leung; Kin-Hung Chow; Cindy Wing-Sze Tse; Vincent Chi-Chung Cheng; Herman Tse; Siu-Ka Mak; Wai-Kei Lo
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-28       Impact factor: 2.803

5.  Staphylococcus lugdunensis in several niches of the normal skin flora.

Authors:  L Bieber; G Kahlmeter
Journal:  Clin Microbiol Infect       Date:  2009-06-06       Impact factor: 8.067

6.  Multiplex PCR assay for identification of six different Staphylococcus spp. and simultaneous detection of methicillin and mupirocin resistance.

Authors:  E Campos-Peña; E Martín-Nuñez; G Pulido-Reyes; J Martín-Padrón; E Caro-Carrillo; J Donate-Correa; I Lorenzo-Castrillejo; J Alcoba-Flórez; F Machín; S Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

7.  Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates.

Authors:  Kristi L Frank; Robin Patel
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

8.  Prevalence and risk factors for carriage of multi-drug resistant Staphylococci in healthy cats and dogs.

Authors:  Paola Gandolfi-Decristophoris; Gertraud Regula; Orlando Petrini; Jakob Zinsstag; Esther Schelling
Journal:  J Vet Sci       Date:  2013-06-28       Impact factor: 1.672

9.  Prevalence of Staphylococcus Species Colonization in Healthy and Sick Cats.

Authors:  K Bierowiec; A Korzeniowska-Kowal; A Wzorek; K Rypuła; A Gamian
Journal:  Biomed Res Int       Date:  2019-01-20       Impact factor: 3.411

10.  Severe Staphylococcus lugdunensis keratitis.

Authors:  N Inada; N Harada; M Nakashima; J Shoji
Journal:  Infection       Date:  2014-08-01       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.